Alcon Inc. (ALC)
NYSE: ALC · Real-Time Price · USD
79.00
-0.67 (-0.84%)
Jan 16, 2026, 4:00 PM EST - Market closed
Alcon Market Cap
Alcon has a market cap or net worth of $39.15 billion as of January 16, 2026. Its market cap has decreased by -6.85% in one year.
Market Cap
39.15B
Enterprise Value
42.87B
1-Year Change
-6.85%
Ranking
Category
Stock Price
$79.00
Market Cap Chart
Since April 9, 2019, Alcon's market cap has increased from $28.35B to $39.15B, an increase of 38.09%. That is a compound annual growth rate of 4.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 39.15B | -0.43% |
| Dec 30, 2025 | 39.32B | -6.24% |
| Dec 30, 2024 | 41.93B | 9.07% |
| Dec 29, 2023 | 38.45B | 14.43% |
| Dec 30, 2022 | 33.60B | -22.39% |
| Dec 30, 2021 | 43.29B | 30.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |